Assessment of potential predictive value o f peripheral blood inflammatory indexes in 26 cases with soft tissue sarcoma treated by pazopanib: a retrospective study


MİRİLİ C., Payday S., GÜNEY İ. B., OĞUL A., GÖKÇAY S., BÜYÜKŞİMŞEK M., ...Daha Fazla

CANCER MANAGEMENT AND RESEARCH, cilt.11, ss.3445-3453, 2019 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 11
  • Basım Tarihi: 2019
  • Doi Numarası: 10.2147/cmar.s191199
  • Dergi Adı: CANCER MANAGEMENT AND RESEARCH
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.3445-3453
  • Anahtar Kelimeler: soft tissue sarcoma, STS, pazopanib, angiogenesis, inflammation, neutrophil-to-lymphocyte ratio, NLR, derived neutrophil-to-lymphocyte ratio, DNLR, PROGNOSTIC-FACTORS, LYMPHOCYTE RATIO, CANCER, ANGIOGENESIS, BIOMARKERS, NEUTROPHIL, SURVIVAL, MONOCYTE
  • Çukurova Üniversitesi Adresli: Evet

Özet

Purpose: The aim of this study was to evaluate the prognostic and predictive value o f neutrophilto-lymphocyte ratio (NLR), derived neutrophil-to-lymphocyte ratio (DNLR), lymphocyte-tomonocyte ratio (LMR), and platelet-to-lymphocyte ratio (PLR) in soft tissue sarcoma (STS) cases treated with pazopanib.